Redirecting mouse CTL against colon carcinoma:: Superior signaling efficacy of single-chain variable domain chimeras containing TCR-ζ vs FcεRI-γ

被引:111
作者
Haynes, NM
Snook, MB
Trapani, JA
Cerruti, L
Jane, SM
Smyth, MJ
Darcy, PK
机构
[1] Peter MacCallum Canc Inst, Canc Immunol Res Lab, Parkville, Vic 8006, Australia
[2] Royal Melbourne Hosp, Rotary Bone Marrow Res Lab, Parkville, Vic 3050, Australia
关键词
D O I
10.4049/jimmunol.166.1.182
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The structurally related TCR-zeta and Fc receptor for IgE (Fc epsilon RI)-gamma are critical signaling components of the TCR and Fc epsilon RI, respectively. Although chimeric Ab receptors containing zeta and gamma signaling chains have been used to redirect CTL to tumors, a direct comparison of their relative efficacy has not previously been undertaken. Here, in naive T lymphocytes, we compare the signaling capacities of the zeta and gamma subunits within single-chain variable domain (scFv) chimeric receptors recognizing the carcinoembryonic Ag (CEA). Using a very efficient retroviral gene delivery system, high and equivalent levels of scFv-zeta and scFv-gamma receptors were expressed in T cells. Despite similar levels of expression and Ag-specific binding to colon carcinoma target cells, ligation of scFv-anti-CEA-zeta chimeric receptors on T cells resulted in greater cytokine production and direct cytotoxicity than activation via scFv-anti-CEA-gamma receptors. T cells expressing scFv-gamma chimeric receptors had a greater capacity to control the growth of human colon carcinoma in scid/scid mice or mouse colon adenocarcinoma in syngeneic C57BL/6 mice. Overall, these data are the first to directly compare and definitively demonstrate the enhanced potency of T cells activated via the zeta signaling pathway.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 40 条
  • [1] Altenschmidt U, 1997, J IMMUNOL, V159, P5509
  • [2] CAMBIER JC, 1995, J IMMUNOL, V155, P3281
  • [3] PHAGE LIBRARIES FOR GENERATION OF CLINICALLY USEFUL ANTIBODIES
    CHESTER, KA
    BEGENT, RHJ
    ROBSON, L
    KEEP, P
    PEDLEY, RB
    BODEN, JA
    BOXER, G
    GREEN, A
    WINTER, G
    COCHET, O
    HAWKINS, RE
    [J]. LANCET, 1994, 343 (8895) : 455 - 456
  • [4] Coligan JE., 1993, Current Protocols in Immunology, V5 14.6.4
  • [5] CURNOW SJ, 1995, IMMUNITY, V3, P427
  • [6] Darcy PK, 1998, EUR J IMMUNOL, V28, P1663, DOI 10.1002/(SICI)1521-4141(199805)28:05<1663::AID-IMMU1663>3.0.CO
  • [7] 2-L
  • [8] Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL
    Darcy, PK
    Haynes, NM
    Snook, MB
    Trapani, JA
    Cerruti, L
    Jane, SM
    Smyth, MJ
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (07) : 3705 - 3712
  • [9] syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction
    ElHillal, O
    Kurosaki, T
    Yamamura, H
    Kinet, JP
    Scharenberg, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1919 - 1924
  • [10] SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS
    ESHHAR, Z
    WAKS, T
    GROSS, G
    SCHINDLER, DG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) : 720 - 724